219 related articles for article (PubMed ID: 15105042)
1. Common gene polymorphisms, cancer progression and prognosis.
Loktionov A
Cancer Lett; 2004 May; 208(1):1-33. PubMed ID: 15105042
[TBL] [Abstract][Full Text] [Related]
2. Mutations and altered expression of the human cancer genes: what they tell us about causes.
Devereux TR; Risinger JI; Barrett JC
IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in research on multistage tumorigenesis.
Compagni A; Christofori G
Br J Cancer; 2000 Jul; 83(1):1-5. PubMed ID: 10883659
[TBL] [Abstract][Full Text] [Related]
4. Clinical, cellular, and molecular aspects of cancer invasion.
Mareel M; Leroy A
Physiol Rev; 2003 Apr; 83(2):337-76. PubMed ID: 12663862
[TBL] [Abstract][Full Text] [Related]
5. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
6. [Biology of solid cancers: breast cancer as an example. First part: genetic systems implicated in carcinogenesis].
Bièche I; Lidereau R
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):131-41. PubMed ID: 8690861
[TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanism of carcinogenesis].
Shibuya M
Gan To Kagaku Ryoho; 1993 Apr; 20(5):677-83. PubMed ID: 8470929
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of tumours derived from rasV12/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development.
Vasseur S; Malicet C; Calvo EL; Dagorn JC; Iovanna JL
Mol Cancer; 2005 Jan; 4(1):4. PubMed ID: 15651998
[TBL] [Abstract][Full Text] [Related]
9. Metabolic susceptibility genes as cancer risk factors: time for a reassessment?
Garte S
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1233-7. PubMed ID: 11751439
[TBL] [Abstract][Full Text] [Related]
10. [Cancer genetics. A review of oncological molecular biology seen in relation to the human genome].
Gerdes AM
Ugeskr Laeger; 2002 May; 164(22):2865-71. PubMed ID: 12082811
[TBL] [Abstract][Full Text] [Related]
11. ETS transcription factors and their emerging roles in human cancer.
Seth A; Watson DK
Eur J Cancer; 2005 Nov; 41(16):2462-78. PubMed ID: 16213704
[TBL] [Abstract][Full Text] [Related]
12. Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia.
Karakosta A; Golias Ch; Charalabopoulos A; Peschos D; Batistatou A; Charalabopoulos K
J Exp Clin Cancer Res; 2005 Dec; 24(4):505-14. PubMed ID: 16471312
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
14. Cancer genetics.
Ponder BA
Nature; 2001 May; 411(6835):336-41. PubMed ID: 11357140
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs.
Fabbri M; Croce CM; Calin GA
Cancer J; 2008; 14(1):1-6. PubMed ID: 18303474
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
17. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
Rak J; Klement P; Yu J
Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic pathways in hereditary and sporadic breast cancer.
Kenemans P; Verstraeten RA; Verheijen RH
Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
[TBL] [Abstract][Full Text] [Related]
19. Somatic alterations and metabolic polymorphisms.
Freedman AN
IARC Sci Publ; 1999; (148):37-50. PubMed ID: 10493247
[TBL] [Abstract][Full Text] [Related]
20. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
